NCT01911728View on ClinicalTrials.gov

Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates

PHASE1CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

July 25, 2011

Primary Completion Date

February 21, 2012

Study Completion Date

February 21, 2012

Conditions

Pharmacokinetics of MDV3100Castration Resistant Prostate Cancer (CRPC)

Interventions

DRUG

MDV3100

Oral

DRUG

Pioglitazone

Oral

DRUG

Warfarin

Oral

DRUG

Omeprazole

Oral

DRUG

Midazolam

Oral

Trial Locations (2)

Unknown

Parexel, George

Parexel/Qdot Pharma, Port Elizabeth

Sponsors

Collaborators (1)

Medivation, Inc.

All Listed Sponsors

collaborator

Medivation, Inc.

INDUSTRY

lead

Astellas Pharma Europe B.V.

INDUSTRY